A Phase 2 Study of Lenalidomide to Evaluate the Efficacy in Japanese Patients With Newly Diagnosed Multiple Myeloma
Clinical trial NCT01698801 · COMPLETED
Trial details
- NCT number
- NCT01698801
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2013-11-26
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.